Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
1.
Neuropharmacology ; 239: 109674, 2023 11 15.
Article in English | MEDLINE | ID: mdl-37541383

ABSTRACT

The molecular processes that underlie long-term memory formation involve signaling pathway activation by neurotransmitter release, which induces the expression of immediate early genes, such as Zif268, having a key role in memory formation. In this work, we show that the cannabinoid CB1 receptor signaling is necessary for the effects of dexamethasone on the behavioral response in an inhibitory avoidance task, on dexamethasone-induced ERK phosphorylation, and on dexamethasone-dependent Zif268 expression. Furthermore, we provide primary evidence for the mechanism responsible for this crosstalk between cannabinoid and glucocorticoid-mediated signaling pathways, showing that dexamethasone regulates endocannabinoid metabolism by inhibiting the activity of the Fatty acid amide hydrolase (FAAH), an integral membrane enzyme that hydrolyzes endocannabinoids and related amidated signaling lipids. Our results provide novel evidence regarding the role of the endocannabinoid system, and in particular of the CB1 receptor, as a mediator of the effects of glucocorticoids on the consolidation of aversive memories.


Subject(s)
Cannabinoids , Memory Consolidation , Endocannabinoids/metabolism , Receptor, Cannabinoid, CB1/genetics , Cannabinoids/pharmacology , Signal Transduction , Glucocorticoids/pharmacology , Dexamethasone/pharmacology , Amidohydrolases , Cannabinoid Receptor Modulators/pharmacology
2.
J Neurochem ; 144(2): 128-138, 2018 01.
Article in English | MEDLINE | ID: mdl-29049850

ABSTRACT

Diabetic retinopathy (DR) is one of the common complications associated with diabetes mellitus and the leading cause of blindness worldwide. Recent research has demonstrated that DR is not only a microvascular disease but may be a result of neurodegenerative processes. Moreover, glucose-induced neuron and glial cell damage may occur shortly after the onset of diabetes which makes the disease hard to diagnose at early stages. SIRT6, a NAD-dependent sirtuin deacylase, modulates aging, energy metabolism, and neurodegeneration. In previous studies we showed that SIRT6 deficiency causes major retinal transmission defects, changes in the expression of glycolytic genes, and elevated levels of apoptosis. Given the importance of glucose availability for retinal function and the critical role of SIRT6 in modulating glycolysis, we aimed to analyze SIRT6 participation in the molecular machinery that regulates the development of experimental DR. Using non-obese diabetic mice, we determined by western blot that 2 weeks after the onset of the disease, high glucose concentrations induced retinal increase in a neovascularization promoting factor (vascular endothelial growth factor, VEGF), and the loss of a neuroprotective factor (brain-derived neurotrophic factor, BDNF) associated with reduced levels of SIRT6 and increased acetylation levels of its substrates (H3K9 and H3K56) suggesting a deregulation of key neural factors. Noteworthy, retinas from CNS conditionally deleted SIRT6 mice showed a resemblance to diabetic retinas exhibiting lower protein levels of BDNF factor and increased protein levels of VEGF. Moreover, cultured Müller glial cells subjected to high glucose concentrations exhibited decreased levels of SIRT6 and increased levels of H3K56 acetylation. In addition, the increment of VEGF levels induced by high glucose was reverted by the over-expression of SIRT6 in this cell type. Accordingly, siRNA experiments showed that, when SIRT6 was silenced, VEGF levels increased. Our findings suggest that epigenetically regulated neurodegenerative events may occur at an early diabetic stage prior to the characteristic proliferative and vascular changes observed at a later diabetic stage.


Subject(s)
Diabetic Retinopathy/genetics , Epigenesis, Genetic , Neurodegenerative Diseases/genetics , Sirtuins/genetics , Animals , Brain-Derived Neurotrophic Factor/biosynthesis , Brain-Derived Neurotrophic Factor/genetics , Diabetic Retinopathy/pathology , Female , Gene Silencing , Glucose/pharmacology , Mice , Mice, Knockout , Neovascularization, Pathologic/chemically induced , Neurodegenerative Diseases/pathology , Neuroglia/metabolism , RNA, Small Interfering/pharmacology , Vascular Endothelial Growth Factor A/biosynthesis , Vascular Endothelial Growth Factor A/genetics
3.
J Pineal Res ; 63(4)2017 Nov.
Article in English | MEDLINE | ID: mdl-28776755

ABSTRACT

Preterm birth is a major contributor to early and delayed physical and cognitive impairment. Epidemiological and experimental data indicate that maternal infections are a significant and preventable cause of preterm birth. Recently, melatonin has been suggested to exert neuroprotective effects in several models of brain injury. Here, we sought to investigate whether the administration of melatonin is able to prevent lipopolysaccharide (LPS)-induced fetal brain damage in a model of LPS-induced preterm labor. For this purpose, 15-day pregnant BALB/c mice received intraperitoneally 2 doses of LPS or vehicle: the first one at 10:00 hours (0.26 mg/kg) and the second at 13:00 hours (0.52 mg/kg). On day 14 of pregnancy, a group of mice was subcutaneously implanted with a pellet of 25 mg melatonin. This experimental protocol resulted in 100% of preterm birth and pup death in the LPS group and a 50% of term birth and pup survival in the melatonin + LPS group. In the absence of melatonin, fetuses from LPS-treated mothers showed histological signs of brain damage, microglial/macrophage activation, and higher levels of IL-1ß, inducible nitric oxide synthase (NOS), and neuronal NOS mRNAs as well as increased histone acetyltransferase activity and histone H3 hyperacetylation. In contrast, antenatal administration of melatonin prevented LPS-induced fetal brain damage. Moreover, when behavioral traits were analyzed in the offspring from control, melatonin, and melatonin + LPS, no significant differences were found, suggesting that melatonin prevented LPS-induced long-term neurodevelopmental impairments. Collectively, our results suggest that melatonin could be a new therapeutic tool to prevent fetal brain damage and its long-term consequences induced by maternal inflammation.


Subject(s)
Birth Injuries/prevention & control , Brain Injuries/prevention & control , Melatonin/pharmacology , Neuroprotective Agents/pharmacology , Premature Birth , Animals , Birth Injuries/etiology , Brain Injuries/etiology , Female , Inflammation/chemically induced , Lipopolysaccharides/toxicity , Mice , Mice, Inbred BALB C , Obstetric Labor, Premature/chemically induced , Pregnancy , Premature Birth/chemically induced
4.
Neurobiol Learn Mem ; 142(Pt A): 135-145, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28285131

ABSTRACT

Acute stress impairs memory retrieval of several types of memories. An increase in glucocorticoids, several minutes after stressful events, is described as essential to the impairing retrieval-effects of stressors. Moreover, memory retrieval under stress can have long-term consequences. Through what process does the reactivated memory under stress, despite the disrupting retrieval effects, modify long-term memories? The reconsolidation hypothesis proposes that a previously consolidated memory reactivated by a reminder enters a vulnerability phase (labilization) during which it is transiently sensitive to modulation, followed by a re-stabilization phase. However, previous studies show that the expression of memories during reminder sessions is not a condition to trigger the reconsolidation process since unexpressed memories can be reactivated and labilized. Here we evaluate whether it is possible to reactivate-labilize a memory under the impairing-effects of a mild stressor. We used a paradigm of human declarative memory whose reminder structure allows us to differentiate between a reactivated-labile memory state and a reactivated but non-labile state. Subjects memorized a list of five cue-syllables associated with their respective response-syllables. Seventy-two hours later, results showed that the retrieval of the paired-associate memory was impaired when tested 20min after a mild stressor (cold pressor stress (CPS)) administration, coincident with cortisol levels increase. Then, we investigated the long-term effects of CPS administration prior to the reminder session. Under conditions where the reminder initiates the reconsolidation process, CPS impaired the long-term memory expression tested 24h later. In contrast, CPS did not show effects when administered before a reminder session that does not trigger reconsolidation. Results showed that memory reactivation-labilization occurs even when retrieval was impaired. Memory reactivation under stress could hinder -via reconsolidation- the probability of the traces to be expressed in the long term.


Subject(s)
Association Learning/physiology , Memory Consolidation/physiology , Mental Recall/physiology , Stress, Physiological/physiology , Blood Pressure/physiology , Cold Temperature , Cues , Female , Humans , Hydrocortisone/analysis , Male , Neuropsychological Tests , Saliva/chemistry
5.
Pharmacol Res ; 109: 64-73, 2016 07.
Article in English | MEDLINE | ID: mdl-26774789

ABSTRACT

Stress is an adaptive response to demands of the environment and thus essential for survival. Exposure to stress during the first years of life has been shown to have profound effects on the growth and development of an adult individual. There are evidences demonstrating that stressful experiences during gestation or in early life can lead to enhanced susceptibility to mental disorders. Early-life stress triggers hypothalamic-pituitary-adrenocortical (HPA) axis activation and the associated neurochemical reactions following glucocorticoid release are accompanied by a rapid physiological response. An excessive response may affect the developing brain resulting in neurobehavioral and neurochemical changes later in life. This article reviews the data from experimental studies aimed to investigate hormonal, functional, molecular and epigenetic mechanisms involved in the stress response during early-life programming. We think these studies might prove useful for the identification of novel pharmacological targets for more effective treatments of mental disorders.


Subject(s)
Stress, Psychological/genetics , Animals , Epigenesis, Genetic , Female , Humans , Hypothalamo-Hypophyseal System , Pituitary-Adrenal System , Pregnancy , Prenatal Exposure Delayed Effects
6.
Vertex ; XXVII(129): 383-392, 2016 Sep.
Article in Spanish | MEDLINE | ID: mdl-28282076

ABSTRACT

Pharmacogenetics studies the action of a drug in order to predict the response based on the genetic makeup of an individual. The objective of pharmacogenetic studies is to minimize the adverse effects and to ensure therapeutic benefit. Since psychotropic drugs have a high rate of variability in patient response, the aim of this paper is to update the pharmacogenetic concepts in psychopharmacology in a review that provides tools for rigorous analysis when prescribing a psychotropic drug. The purpose of clinical pharmacogenetic testing is to be able to distinguish between patients who are more or less responders to certain drugs, or on contrary, who are at increased risk for adverse events. The goal is to choose a drug therapy that can maximize the effectiveness in the treatment and minimize the risks of adverse reactions, thus improving the benefit / risk ratio. IN CONCLUSION: technology is not a limiting factor nowadays; the challenge remains, however, to further develop research for clinical use, establishing an appropriate validation test, that is accurate, repeatable and reproducible, in order to safely detect gene sequences of clinical interest.


Subject(s)
Mental Disorders/drug therapy , Mental Disorders/genetics , Pharmacogenetics , Psychiatry , Cytochrome P-450 Enzyme System/genetics , Humans
7.
Adv Neurobiol ; 10: 61-74, 2015.
Article in English | MEDLINE | ID: mdl-25287536

ABSTRACT

Several studies suggest that negative emotions during pregnancy generate adverse effects on the cognitive, behavioural and emotional development of the descendants. The psychoneuroendocrine pathways involve the transplacentary passage of maternal glucocorticoids in order to influence directly on fetal growth and brain development.Nitric oxide is a gaseous neurotransmitter that plays an important role in the control of neural activity by diffusing into neurons and participates in learning and memory processes. It has been demonstrated that nitric oxide is involved in the regulation of corticosterone secretion. Thus, it has been found that the neuronal isoform of nitric oxide synthase (nNOS) is an endogenous inhibitor of glucocorticoid receptor (GR) in the hippocampus and that nNOS in the hippocampus may participate in the modulation of hypothalamic-pituitary-adrenal axis activity via GR.Neurotrophins are a family of secreted growth factors consisting of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT3) and NT4. Although initially described in the nervous system, they regulate processes such as cell survival, proliferation and differentiation in several other compartments. It has been demonstrated that the NO-citrulline cycle acts together with BDNF in maintaining the progress of neural differentiation.In the present chapter, we explore the interrelation between nitric oxide, glucocorticoids and neurotrophins in brain areas that are key structures in learning and memory processes. The participation of this interrelation in the behavioural and cognitive alterations induced in the offspring by maternal stress is also addressed.

8.
Open Cardiovasc Med J ; 7: 90-8, 2013.
Article in English | MEDLINE | ID: mdl-24155799

ABSTRACT

The pathogenesis of atherosclerosis includes the assignment of a critical role to cells of the monocyte/macrophage lineage and to pro-inflammatory cytokines. Niacin is known to improve lipid metabolism and to produce beneficial modification of cardiovascular risk factors. The aim of this work was to investigate if Niacin is able to modulate pro-inflammatory cytokine production in macrophages in a murine model of atherosclerosis. For this purpose C57Bl/6J mice fed with atherogenic diet (AGD) or with conventional chow diet were used. The AGD group showed an increase in body weight and in total plasma cholesterol, with no differences in triglyceride or HDL levels. Lesions in arterial walls were observed. The characterization of Niacin receptor showed an increase in the receptor number of macrophages from the AGD group. Macrophages from control and AGD animals treated in vitro with an inflammatory stimulus showed elevated levels of IL-6, IL-1 and TNF-α, that were even higher in macrophages from AGD mice. Niacin was able to decrease the production of pro-inflammatory cytokines in stimulated macrophages. Similar effect of Niacin was observed in an in vivo model of inflammation. These results show an attenuating inflammatory mechanism for this therapeutic agent and would point out its potential action in plaque stabilization and in the prevention of atherosclerosis progression. Furthermore, the present results provide the basis for future studies on the potential contribution of Niacin to anti-inflammatory therapies.

9.
Neurochem Int ; 61(8): 1294-301, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23022609

ABSTRACT

Prenatal stress (PS) has been linked to abnormal cognitive, behavioral and psychosocial outcomes in both animals and humans. Since PS has been shown to induce a cerebellar cytoarchitectural disarrangement and cerebellar abnormalities that have been linked to an impairment of behavioral functions, the aim of the present work was to investigate whether the exposure to PS in a period in which the cerebellum is still immature can induce behavioral deficits in the adult and whether this alterations are correlated with changes in nitric oxide (NO) and cellular oxidative mechanisms in offspring's cerebellum. Our results show impairments in spatial memory and territory discrimination in PS adult rats. PS offspring also displayed alterations in cerebellar nitric oxide synthase (NOS) expression and activity. Moreover, a correlation between spatial memory deficits and the increase in NOS activity was found. The results found here may point to a role of cerebellar NO in the behavioral alterations induced by stress during early development stages.


Subject(s)
Cerebellum/metabolism , Memory Disorders/etiology , Nitric Oxide/metabolism , Pregnancy Complications/physiopathology , Prenatal Exposure Delayed Effects , Restraint, Physical/adverse effects , Stress, Psychological/physiopathology , Animals , Exploratory Behavior/physiology , Female , Male , Maze Learning/physiology , Memory Disorders/metabolism , Nitric Oxide Synthase Type I/biosynthesis , Nitric Oxide Synthase Type I/genetics , Oxidative Stress , Pregnancy , Pregnancy Complications/etiology , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Random Allocation , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Stress, Psychological/etiology
10.
Neuroimmunomodulation ; 19(5): 293-303, 2012.
Article in English | MEDLINE | ID: mdl-22777139

ABSTRACT

OBJECTIVE: Periodontitis is an infectious disease leading to inflammation and destruction of tissue surrounding and supporting the tooth. The progress of the inflammatory response depends on the host's immune system and risk factors such as stress. The aim of the present study was to investigate the role of the endocannabinoid anandamide (AEA) in experimental periodontitis with restraint stress, since the endocannabinoid system is known to modulate the hypothalamo-pituitary-adrenal axis as well as immune functions and has been found in human gingival tissues. METHODS: Experimental periodontitis was induced by ligature around first inferior molars and immobilization stress for 2 h twice daily for 7 days in a rat model. RESULTS: Corticosterone plasma levels, locomotor activity, adrenal gland weight and bone loss were increased in periodontitis and stress groups, and there was also less weight gain. The inflammatory parameters such as prostaglandin E(2) (radioimmunoassay), nitric oxide (radioconversion of (14)C-arginine), tumor necrosis factor (TNF)-α (ELISA) and interleukin (IL)-1ß (Western blot) measured in the gingival tissue were significantly increased in the periodontitis groups compared to the control group. Local injection of AEA (10(-8)M, 30 µl) decreased corticosterone plasma levels and the content of the cytokines TNF-α and IL-1ß in gingival tissue in periodontitis-stress groups. These AEA-induced inhibitions were mediated by CB(1) and CB(2) cannabinoid receptors since the injection of both antagonists together, AM251 (10(-6)M) and AM630 (10(-6)M) in 30 µl, prevented these effects. CONCLUSION: The endocannabinoid AEA diminishes the inflammatory response in periodontitis even during a stressful situation.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Arachidonic Acids/therapeutic use , Cannabinoid Receptor Agonists/therapeutic use , Endocannabinoids/therapeutic use , Periodontitis/drug therapy , Polyunsaturated Alkamides/therapeutic use , Stress, Psychological/drug therapy , Alveolar Bone Loss/etiology , Alveolar Bone Loss/pathology , Animals , Body Weight/drug effects , Corticosterone/blood , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Exploratory Behavior/drug effects , Indoles/therapeutic use , Interleukin-1beta/metabolism , Male , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Periodontitis/blood , Periodontitis/physiopathology , Piperidines/therapeutic use , Prostaglandins E/metabolism , Pyrazoles/therapeutic use , Rats , Rats, Wistar , Statistics, Nonparametric , Stress, Psychological/blood , Stress, Psychological/physiopathology , Tumor Necrosis Factor-alpha/metabolism
11.
Psicofarmacologia (B. Aires) ; 12(73): 9-20, apr. 2012. ilus
Article in Spanish | LILACS | ID: lil-653244

ABSTRACT

Los cambios a largo plazo que se producen en estructura y función del cerebro que acompañan a la exposición crónica a drogas de abuso sugieren que las alteraciones en la regulación de genes contribuyen sustancialmente al fenotipo adictivo. En este capítulo se examinan los múltiples mecanismos por los cuales las drogas alteran el potencial de la transcripción de los genes. Estos mecanismos van desde la movilización o la represión de la maquinaria transcripcional - incluyendo los factores de transcripción DFOSB, el AMP cíclico que responde a las proteínas de elemento de respuesta (CREB) y el factor nuclear-kB (NF-kB) - a la epigenética - incluidas las modificaciones en la accesibilidad de los genes dentro de su estructura de la cromatina nativa inducida por las modificaciones de la cola de histonas y la metilación del ADN, y la regulación de la expresión génica mediante ARN no codificantes. Todas las investigaciones evidencian diversos mecanismos de regulación de genes que inducen las drogas de abuso generando cambios duraderos en el cerebro, y esta revisión describe novedosas propuestas para la terapia de la adicción.


Long-term changes which result from the chronic exposure to substances of abuse suggest that the alterations in the regulation of genes contribute substantially to the pro-addictive phenotype. These drugs after multiple mechanisms, which include the motility or repression of the transcriptional machinery, as well as epigenetics, and non-coding RNAs regions. All the research evidences different gene regulatory mechanisms induce by substances of abuse, which generate sustainable changes in the brain.


Subject(s)
Humans , Transcriptional Activation , Cyclic AMP Response Element-Binding Protein , Gene Expression Regulation , Substance-Related Disorders/pathology , Substance-Related Disorders/therapy
12.
Psicofarmacologia (B. Aires) ; 12(73): 9-20, apr. 2012. ilus
Article in Spanish | BINACIS | ID: bin-129444

ABSTRACT

Los cambios a largo plazo que se producen en estructura y función del cerebro que acompañan a la exposición crónica a drogas de abuso sugieren que las alteraciones en la regulación de genes contribuyen sustancialmente al fenotipo adictivo. En este capítulo se examinan los múltiples mecanismos por los cuales las drogas alteran el potencial de la transcripción de los genes. Estos mecanismos van desde la movilización o la represión de la maquinaria transcripcional - incluyendo los factores de transcripción DFOSB, el AMP cíclico que responde a las proteínas de elemento de respuesta (CREB) y el factor nuclear-kB (NF-kB) - a la epigenética - incluidas las modificaciones en la accesibilidad de los genes dentro de su estructura de la cromatina nativa inducida por las modificaciones de la cola de histonas y la metilación del ADN, y la regulación de la expresión génica mediante ARN no codificantes. Todas las investigaciones evidencian diversos mecanismos de regulación de genes que inducen las drogas de abuso generando cambios duraderos en el cerebro, y esta revisión describe novedosas propuestas para la terapia de la adicción.(AU)


Long-term changes which result from the chronic exposure to substances of abuse suggest that the alterations in the regulation of genes contribute substantially to the pro-addictive phenotype. These drugs after multiple mechanisms, which include the motility or repression of the transcriptional machinery, as well as epigenetics, and non-coding RNAs regions. All the research evidences different gene regulatory mechanisms induce by substances of abuse, which generate sustainable changes in the brain.(AU)


Subject(s)
Humans , Substance-Related Disorders/pathology , Gene Expression Regulation/drug effects , Substance-Related Disorders/therapy , Cyclic AMP Response Element-Binding Protein/drug effects , Transcriptional Activation/drug effects
13.
Psicofarmacologia (B. Aires) ; 12(73): 9-20, apr. 2012. ilus
Article in Spanish | BINACIS | ID: bin-127625

ABSTRACT

Los cambios a largo plazo que se producen en estructura y función del cerebro que acompañan a la exposición crónica a drogas de abuso sugieren que las alteraciones en la regulación de genes contribuyen sustancialmente al fenotipo adictivo. En este capítulo se examinan los múltiples mecanismos por los cuales las drogas alteran el potencial de la transcripción de los genes. Estos mecanismos van desde la movilización o la represión de la maquinaria transcripcional - incluyendo los factores de transcripción DFOSB, el AMP cíclico que responde a las proteínas de elemento de respuesta (CREB) y el factor nuclear-kB (NF-kB) - a la epigenética - incluidas las modificaciones en la accesibilidad de los genes dentro de su estructura de la cromatina nativa inducida por las modificaciones de la cola de histonas y la metilación del ADN, y la regulación de la expresión génica mediante ARN no codificantes. Todas las investigaciones evidencian diversos mecanismos de regulación de genes que inducen las drogas de abuso generando cambios duraderos en el cerebro, y esta revisión describe novedosas propuestas para la terapia de la adicción.(AU)


Long-term changes which result from the chronic exposure to substances of abuse suggest that the alterations in the regulation of genes contribute substantially to the pro-addictive phenotype. These drugs after multiple mechanisms, which include the motility or repression of the transcriptional machinery, as well as epigenetics, and non-coding RNAs regions. All the research evidences different gene regulatory mechanisms induce by substances of abuse, which generate sustainable changes in the brain.(AU)


Subject(s)
Humans , Substance-Related Disorders/pathology , Gene Expression Regulation , Substance-Related Disorders/therapy , Cyclic AMP Response Element-Binding Protein , Transcriptional Activation
14.
Arch Oral Biol ; 57(9): 1211-7, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22424886

ABSTRACT

OBJECTIVE: The aim of this study was to assess the short term effect of ethanol administration on periodontal disease in rats. DESIGN: Rats received either ethanol 2g/kg or water by gastric gavage twice a day. On the fifth day ligatures were tied around the molars of half of the rats to induce periodontitis. After 7days gingival tissue was removed and assayed for inflammatory markers. Finally, hemi-mandibles were extracted to evaluate bone loss by histomorphometrical techniques. RESULTS: The experimental periodontitis increased significantly the mRNA expression (p<0.001) and activity (p<0.001) of inducible nitric oxide synthase (iNOS) in the gingival tissue, whilst short time ethanol administration increased iNOS activity (p<0.05) and produced an additive effect on iNOS mRNA expression augmented by periodontitis (p<0.01). The short time ethanol administration also potentiated the periodontitis stimulatory effect on the mRNA expression of interleukin (IL)-1ß (p<0.01 and p<0.001, in semi-quantitative and real time PCR, respectively) and on the height of periodontal ligament (p<0.05). However, the ligature-induced periodontitis, but not ethanol administration, increased the prostaglandin E(2) content (p<0.05) and, diminished the alveolar bone volume (p<0.05), as compared to sham rats. CONCLUSION: The present results suggest that ethanol consumption could represent a risk indicator for periodontal disease since augments the expression of inflammatory markers, in healthy rats, and increases them, at short term, during the illness. However, scale longitudinal investigation and more case-control studies are needed to confirm this statement.


Subject(s)
Alcoholic Beverages/adverse effects , Ethanol/adverse effects , Inflammation Mediators/analysis , Periodontitis/pathology , Alveolar Bone Loss/pathology , Alveolar Process/pathology , Animals , Anti-Inflammatory Agents/blood , Biomarkers/analysis , Chromatography, High Pressure Liquid , Corticosterone/blood , Dinoprostone/analysis , Gingiva/chemistry , Gingiva/enzymology , Interleukin-1beta/analysis , Male , Nitric Oxide Synthase Type II/analysis , Periodontal Ligament/pathology , Periodontitis/metabolism , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Risk Factors
15.
Brain Behav Immun ; 26(3): 429-38, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22200600

ABSTRACT

Long-term exposure to stressful situations has deleterious effects on adult neurogenesis, behavior, and the immune system. We have previously shown that stressed BALB/c mice show poor learning performance, which correlates with an increase in the T helper 1/T helper 2 (Th1/Th2) cytokine balance. Glatiramer acetate (GA) can stimulate autoreactive T cells. In this work we investigated the effects of GA treatment on BALB/c mice exposed to chronic mild stress (CMS). Stressed mice exhibited a significant decline in their performance in the open field and Y-maze tasks, which was accompanied by a reduction in dentate gyrus neurogenesis and an altered Th1/Th2 balance. Interestingly, after 6 weeks of CMS exposure administration of GA reestablished normal levels of adult neurogenesis, restored the Th1/Th2 balance, and improved learning performance. These results demonstrate that GA treatment can reverse the learning impairment induced by stress through a mechanism that likely involves the regulation of the cytokine balance and adult neurogenesis.


Subject(s)
Adjuvants, Immunologic/pharmacology , Hippocampus/drug effects , Neurogenesis/drug effects , Peptides/pharmacology , Stress, Psychological/immunology , Th1-Th2 Balance/drug effects , Animals , Behavior, Animal/drug effects , Cytokines/drug effects , Female , Glatiramer Acetate , Mice , Mice, Inbred BALB C
16.
J Neurochem ; 118(4): 626-35, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21631508

ABSTRACT

Ionizing radiations can induce oxidative stress on target tissues, acting mainly through reactive oxygen species (ROS). The aim of this work was to investigate if 17-ß-estradiol (ßE) was able to prevent hippocampal-related behavioral and biochemical changes induced by neonatal ionizing radiation exposure and to elucidate a potential neuroprotective mechanism. Male Wistar rats were irradiated with 5 Gy of X-rays between 24 and 48 h after birth. A subset of rats was subcutaneously administered with successive injections of ßE or 17-α-estradiol (αE), prior and after irradiation. Rats were subjected to different behavioral tasks to evaluate habituation and associative memory as well as anxiety levels. Hippocampal ROS levels and protein kinase C (PKC) activity were also assessed. Results show that although ßE was unable to prevent radiation-induced hippocampal PKC activity changes, most behavioral abnormalities were reversed. Moreover, hippocampal ROS levels in ßE-treated irradiated rats approached control values. In addition, αE administered to irradiated animals was effective in preventing radiation-induced alterations. In conclusion, ßE was able to counteract behavioral and biochemical changes induced in irradiated animals, probably acting through an antioxidant mechanism.


Subject(s)
Animals, Newborn , Estradiol/pharmacology , Neuroprotective Agents , Radiation-Protective Agents , Animals , Antioxidants/metabolism , Anxiety/psychology , Avoidance Learning/drug effects , Avoidance Learning/radiation effects , Female , Habituation, Psychophysiologic/drug effects , Habituation, Psychophysiologic/radiation effects , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/radiation effects , Male , Memory/drug effects , Motor Activity/drug effects , Motor Activity/radiation effects , Pregnancy , Protein Kinase C/metabolism , Radiation Injuries, Experimental/prevention & control , Rats , Reactive Oxygen Species/metabolism , Reactive Oxygen Species/radiation effects , Time , X-Rays
17.
J Biol Rhythms ; 26(2): 107-17, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21454291

ABSTRACT

Regeneration and growth that occur in the adult teleost retina have been helpful in identifying molecular and cellular mechanisms underlying cell proliferation and differentiation. Here, it is reported that S-phase cell number, in the ciliary marginal zone (CMZ) of the adult zebrafish retina, exhibits day-night variations with a mid-light phase peak. Oscillations persist for 24 h in constant darkness (DD), suggesting control by a circadian component. However, variations in the S-phase nuclei number were rapidly dampened and not present during and after a second day in DD. An ADPßS treatment significantly enhanced S-phase activity at night to mid-light levels, as assessed by in vivo BrdU incorporation in a 2-h interval. Moreover, daylight increase in S-phase cell number was completely abolished when extracellular nucleotide levels or their extracellular hydrolysis by ectonucleoside triphosphate diphosphohydrolases (NTPDases) were significantly disrupted or when a selective antagonist of purinergic P2Y1 receptors was intraocularly injected before BrdU exposure. Extracellular nucleotides and NTPDase action were also important for maintaining nocturnal low levels of S-phase activity in the CMZ. Finally, we showed that mRNAs of NTPDases 1, 2 (3 isoforms), and 3 as well as of P2Y1 receptor are present in the neural retina of zebrafish. NTPDase mRNA expression exhibited a 2-fold increment in light versus dark conditions as assessed by quantitative RT-PCR, whereas P2Y1 receptor mRNA levels did not show significant day-night variations. This study demonstrates a key role for nucleotides, principally ADP as a paracrine signal, as well as for NTPDases, the plasma membrane-bound enzymes that control extracellular nucleotide concentration, for inducing S-phase cell entry in the CMZ-normally associated with retinal growth-throughout the light-dark cycle.


Subject(s)
Receptors, Purinergic P2Y1/metabolism , Retina/metabolism , S Phase/physiology , Adenosine Diphosphate/analogs & derivatives , Adenosine Diphosphate/metabolism , Adenosine Diphosphate/pharmacology , Adenosine Triphosphate/metabolism , Animals , Apyrase/pharmacology , Cell Differentiation/drug effects , Cell Nucleus/metabolism , Circadian Clocks/physiology , Enzyme Inhibitors/pharmacology , Extracellular Space/metabolism , Hexokinase/pharmacology , Photoperiod , Purinergic P2Y Receptor Antagonists/pharmacology , Pyrophosphatases/genetics , Pyrophosphatases/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Purinergic P2Y1/genetics , Retina/cytology , Retina/enzymology , S Phase/drug effects , Signal Transduction , Thionucleotides/pharmacology , Zebrafish
18.
Neurochem Int ; 58(3): 273-80, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21163312

ABSTRACT

Acute and long-term complications can occur in patients receiving radiation therapy. It has been suggested that cytoprotection might decrease the incidence and severity of therapy-related toxicity in these patients. Developing cerebellum is highly radiosensitive and for that reason it is a useful structure to test potential neuroprotective substances to prevent radiation induced abnormalities. Recent studies have shown that estrogen can rapidly modulate intracellular signalling pathways involved in cell survival. Thus, it has been demonstrated that estrogens mediate neuroprotection by promoting growth, cell survival and by preventing axonal pruning. The aim of this work was to evaluate the effect of the treatment with 17-ß-estradiol on the motor, structural and biochemical changes induced by neonatal ionizing radiation exposure, and to investigate the participation of nitric oxide and protein kinase C, two important intracellular messengers involved in neuronal activity. Our results show that perinatal chronic 17-ß-estradiol treatment partially protects against radiation-induced cerebellar disorganization and motor abnormalities. PKC and NOS activities could be implicated in its neuroprotective mechanisms. These data provide new evidence about the mechanisms underlying estrogen neuroprotection, which could have therapeutic relevance for patients treated with radiotherapy.


Subject(s)
Brain Damage, Chronic/drug therapy , Cerebellar Diseases/drug therapy , Estradiol/pharmacology , Neuroprotective Agents/pharmacology , Radiation Injuries, Experimental/drug therapy , Radiation Injuries, Experimental/metabolism , Animals , Animals, Newborn , Brain Damage, Chronic/etiology , Brain Damage, Chronic/prevention & control , Cerebellar Diseases/etiology , Cerebellar Diseases/prevention & control , Female , Gamma Rays , Male , Radiation Injuries, Experimental/etiology , Rats , Rats, Wistar
19.
J Neuroimmunol ; 221(1-2): 32-41, 2010 Apr 15.
Article in English | MEDLINE | ID: mdl-20207018

ABSTRACT

This study investigated the participation of the hypothalamic endocannabinoid system in the response to lipopolysaccharide (LPS) challenge evaluating oxytocin (OXT) and tumor necrosis factor-alpha (TNF-alpha) plasma levels in vivo and their release from hypothalamic fragments in vitro. LPS increased OXT and TNF-alpha release through anandamide-activation of hypothalamic cannabinoid receptor CB(1,) since the antagonist AM251 blocked this effect. Anandamide, through its receptors, also increased hypothalamic nitric oxide (NO) which inhibited OXT release, ending the stimulatory effect of the endocannabinoid. Our findings reveal a hypothalamic interaction between oxytocin, endocannabinoid and NO-ergic systems providing a regulation of the hypothalamic-neurohypophyseal axis under basal and stress conditions.


Subject(s)
Cannabinoid Receptor Modulators/metabolism , Endocannabinoids , Hypothalamus/drug effects , Lipopolysaccharides/pharmacology , Oxytocin/blood , Tumor Necrosis Factor-alpha/blood , Analysis of Variance , Animals , Arachidonic Acids/pharmacology , Benzamides/pharmacology , Cannabinoid Receptor Modulators/antagonists & inhibitors , Cannabinoid Receptor Modulators/pharmacology , Carbamates/pharmacology , Enzyme-Linked Immunosorbent Assay/methods , Gene Expression Regulation/drug effects , Hypothalamus/metabolism , Indoles/pharmacology , Male , Nitric Oxide/metabolism , Polyunsaturated Alkamides/pharmacology , Radioimmunoassay/methods , Rats , Rats, Sprague-Dawley , Receptor, Cannabinoid, CB1/genetics , Receptor, Cannabinoid, CB1/metabolism
20.
Neuroimmunomodulation ; 17(3): 153-6, 2010.
Article in English | MEDLINE | ID: mdl-20134190

ABSTRACT

The hypothalamo-neurohypophyseal system plays a role in homeostasis under a variety of stress conditions, including endotoxemia. Oxytocin (OXT) and vasopressin (VP) are important hormones synthesized by neurons in the hypothalamic paraventricular and supraoptic nuclei and released into different brain regions and from the neurohypophyseal terminals into the blood in response to many patho-physiological stimuli. However, the mechanism that controls OXT and VP secretion has not been fully elucidated. Nitric oxide (NO) is a known mediator that regulates the release of these hormones. The endocannabinoid system is a new intercellular system that modulates several neuroendocrine actions. Endocannabinoids (eCB) are released as retrograde messengers by many neurons, including hypothalamic magnocellular neurons and cannabinoid receptors are localized within these neurons, as well as in the anterior and posterior pituitary lobes, suggesting an eCB role in the production and release of OXT and VP. Lipopolysaccharide (LPS) injection is a model used as immune challenge. LPS causes a neuroendocrine response that is mediated by cytokines, tumor necrosis factor-alpha being one of them. We focused on NO and endocannabinoid system participation on OXT and VP production and secretion during basal and stress conditions and found that eCB affect basal OXT and VP secretion by acting differently at each level of the hypothalamo-neurohypophyseal system. After LPS, there is an increase in eCB synthesis that enhances OXT secretion.


Subject(s)
Cannabinoid Receptor Modulators/metabolism , Endocannabinoids , Hypothalamo-Hypophyseal System/metabolism , Neurosecretory Systems/metabolism , Oxytocin/metabolism , Stress, Physiological/immunology , Vasopressins/metabolism , Animals , Cytokines/metabolism , Humans , Hypothalamo-Hypophyseal System/immunology , Inflammation/immunology , Inflammation/metabolism , Inflammation/physiopathology , Neurosecretory Systems/immunology , Nitric Oxide/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...